Immunology and immunotherapy in breast cancer
Immuno-oncology is a rapidly developing field in medicine. Drug combination therapies have already been studied in many clinical trials on various tumor types. In recent years, a checkpoint inhibition therapy with monoclonal antibodies targeting PD-1 and its ligand PD-L1 has been developed. Breast c...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
China Anti-Cancer Association
2022-05-01
|
| Серии: | Cancer Biology & Medicine |
| Предметы: | |
| Online-ссылка: | https://www.cancerbiomed.org/content/19/5/609 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|